Chandigarh, Sept. 8 -- A trial conducted by the Post Graduate Institute of Medical Education and Research (PGIMER) has shown that high-risk breast cancer patients can complete radiotherapy in just one week instead of the standard two, reducing hospital visits and waiting time without compromising safety or results.

The five-year study, titled "Hypofractionated Adjuvant Radiotherapy in 1 versus 2 weeks in High-Risk Patients with Breast Cancer (HYPART): Acute Toxicity Results", analysed 941 patients with stage 2 and 3 breast cancer, aged 21 to 75 years.

After surgery, some breast cancer patients need radiotherapy. Most Indian hospitals, including AIIMS Delhi, follow a three-week standard, but PGIMER has been offering a two-week radiothera...